Gwang Cho - Humasis Director

205470 Stock  KRW 1,885  75.00  4.14%   

Insider

Gwang Cho is Director of Humasis Co
Age 53
Phone82 31 478 8580
Webhttp://www.humasis.com

Humasis Management Efficiency

The company has return on total asset (ROA) of 0.4052 % which means that it generated a profit of $0.4052 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 117.3403 %, meaning that it generated $117.3403 on every $100 dollars invested by stockholders. Humasis' management efficiency ratios could be used to measure how well Humasis manages its routine affairs as well as how well it operates its assets and liabilities.
Humasis Co has accumulated 2.25 B in total debt with debt to equity ratio (D/E) of 0.18, which may suggest the company is not taking enough advantage from borrowing. Humasis has a current ratio of 5.12, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Humasis until it has trouble settling it off, either with new capital or with free cash flow. So, Humasis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Humasis sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Humasis to invest in growth at high rates of return. When we think about Humasis' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 13 records

INSIDER Age

Kim KyoonUNISEM Co
64
HaeJoon ParkSeegene
62
JinSoo ChoiSeegene
71
Richard CreagerSeegene
70
JongKi KimSeegene
58
ByungKyun HamSeegene
55
JongYoon ChunSeegene
66
JongGi CheonSeegene
61
Sung ChinLabGenomics Co
55
Lee KooUNISEM Co
61
HakSoo LeeSeegene
67
BooHyun YangSeegene
58
Cho BumUNISEM Co
61
Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. The company was founded in 2000 and is based in Anyang, South Korea. HUMASIS is traded on Korean Securities Dealers Automated Quotations in South Korea. Humasis Co (205470) is traded on KOSDAQ in Korea and employs 87 people.

Management Performance

Humasis Leadership Team

Elected by the shareholders, the Humasis' board of directors comprises two types of representatives: Humasis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Humasis. The board's role is to monitor Humasis' management team and ensure that shareholders' interests are well served. Humasis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Humasis' outside directors are responsible for providing unbiased perspectives on the board's policies.
Gwang Cho, Director
Hyeong Kim, Internal Auditor
Seong Yim, Non-Executive Independent Director
Jeong Cha, Chief Executive Officer, Director
Yin Cho, Non-Executive Independent Director
Jeong Kim, Director
Seok Lee, Director

Humasis Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Humasis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Humasis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Humasis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humasis will appreciate offsetting losses from the drop in the long position's value.

Moving together with Humasis Stock

  0.79950130 Access BioPairCorr

Moving against Humasis Stock

  0.31226400 OsteonicPairCorr
The ability to find closely correlated positions to Humasis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Humasis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Humasis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Humasis Co to buy it.
The correlation of Humasis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Humasis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Humasis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Humasis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Humasis Stock

Humasis financial ratios help investors to determine whether Humasis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humasis with respect to the benefits of owning Humasis security.